Major League Baseball announced that Braves outfielder Jurickson Profar has been suspended for 162 games after testing positive for exogenous testosterone, a performance-enhancing substance. The ban goes into effect on Friday and will cost him the entire 2026 season, including the playoffs. It’s the second career PED suspension for Profar, who missed 80 games last year after testing positive for Chorionic Gonadotropin.
Ken Rosenthal of The Athletic reports that the Players Association plans to file a grievance challenging this suspension. MLB generally does not announce violations of the drug policy until after the appeal process plays out, as the player is usually allowed to continue playing pending that appeal. Rosenthal writes that Profar’s suspension, by contrast, is not stayed because it’s his second career PED ban. However, the process will be expedited to quickly reach a final resolution.
It’s rare for a player’s PED suspension to be overturned on appeal. Assuming the suspension stands, Profar will not be paid his $15MM salary this season. The Curacao native is also barred from representing the Netherlands in the upcoming World Baseball Classic.
“We were incredibly disappointed to learn that Jurickson tested positive for a performance-enhancing substance and is in violation of MLB’s Drug Prevention and Treatment Program,” the Braves said in a press release. “Our players are consistently educated about the Program and the consequences if they are found to be in violation.”
Profar, who turned 33 a couple weeks ago, was entering the second season of a three-year, $42MM contract. Last year’s suspension cost him just under $6MM of his $12MM salary in year one of that free agent deal. He’s signed through the 2027 season and is owed a $15MM salary again in the contract’s final year. If he incurs a third positive test in his career, he would receive a lifetime ban.
As a teenager, Profar was ranked as the top prospect in the entire sport. A switch-hitting shortstop with a tantalizing blend of power, speed and defensive aptitude, he was hailed as a future star but saw his career derailed by multiple shoulder injuries. He missed nearly the entire 2014 and 2015 campaigns due to shoulder surgery.
The version of Profar that returned looked far different. He hit .227/.316/.315 in 377 MLB plate appearances from 2016-17 before turning in a solid offensive season in 2018. His defense at shortstop had become untenable following the shoulder troubles. Profar spent time at second base and first base before being traded to the A’s, who had him for only one disappointing year before trading him to the Padres.
Profar had an up-and-down run in San Diego. He had an awful start in the shortened 2020 season before a torrid three-week finish to the 60-game season salvaged his batting line. A clear favorite of Padres GM A.J. Preller — who signed him as an international amateur during his days as a Rangers assistant GM — Profar inked a three-year deal following that season but flopped with a .227/.329/.320 slash in year one of the contract. He chose to forgo an opt-out opportunity, returned to San Diego for the 2022 season, turned in a better offensive performance opted out of a net $6.5MM to again test the open market.
Free agency was cold to Profar that winter. He wound up signing with the Rockies just prior to Opening Day 2023 on a $7.75MM deal. Colorado released Profar after he hit just .236/.316/.364 in 111 games. He re-signed in San Diego for the remainder of the season and hit well in 14 games late that year. Profar spent the entire offseason twisting in the winds of free agency before the Padres brought him aboard on a one-year, $1MM deal that looked like the steal of the offseason when he erupted with a .280/.380/.459 batting line in a career-best showing.
That performance prompted the Braves’ three-year, $42MM deal, but it will now forever be met with a healthy dose of skepticism. Profar missed 80 games last year, hit .248/.358/.446 in 355 plate appearances upon returning, and now won’t take another plate appearance until at least 2027. Of course, it remains to be seen whether the Braves will welcome him back or look to move on entirely.
That question doesn’t need to be answered for the time being. Profar can and will be placed on the restricted list, where he won’t be paid or count against Atlanta’s 40-man roster. The Braves will not only save on Profar’s $15MM salary — they’ll also dodge the 20% tax they’d been paying for him as a team that was over the luxury threshold. It amounts to an overall $18MM in savings for Atlanta, which gives the Braves some intriguing possibilities late in the offseason.
Atlanta has incurred a pair of notable injuries in the rotation. Righties Spencer Schwellenbach and Hurston Waldrep both underwent elbow surgery to remove loose bodies/bone spurs. It’s not yet clear when they’ll return, but Schwellenbach is already on the 60-day IL and Waldrep will surely follow.
That’s left the Braves with Chris Sale, Spencer Strider, Reynaldo Lopez (who made just one start last year due to shoulder surgery) and Grant Holmes (who had a UCL tear last summer and rehabbed without surgery) in the top four spots of the rotation. Bryce Elder, Joey Wentz, Didier Fuentes and Jose Suarez are the fifth starter options on the 40-man roster. Non-roster invitees include veterans Martin Perez, Carlos Carrasco and Elieser Hernandez, as well as top prospect JR Ritchie.
Notable veterans like Lucas Giolito, Zack Littell and Tyler Anderson remain unsigned in free agency. Atlanta’s outfield group, of course, takes a hit following the Profar suspension, although the team’s November signing of Mike Yastrzemski means the Braves won’t necessarily need to add another outfielder. Yastrzemski, Michael Harris II and Ronald Acuña Jr. can start on most days, though Acuña has had his share of recent injury troubles and Yastrzemski has long-running platoon issues. Righty hitters Eli White and Jorge Mateo are already on the roster as potential complements, but neither has even average career numbers against left-handed pitching.
Atlanta still projects to be just north of the $244MM luxury threshold, but the front office suddenly has an influx of cash that could be used to acquire additional help, be it another starting pitcher or a veteran right-handed bat to plug into the lineup. Time will tell whether those funds are put to immediate use or saved for in-season additions to the roster, but the Braves immediately become a team to watch with regard to a potential late-offseason addition.
Jeff Passan of ESPN first reported Profar was facing a 162-game PED ban. Image courtesy of Jonathan Dyer, Imagn Images.
